Skip to main content
Clinical Trials/NCT06654362
NCT06654362CompletedNot Applicable

The Effect of Multimodal Nutrition Intervention on Glucose and Lipid Parameters of Arfa Iron and Steel Company Workers

Peyman Sarsangi1 site in 1 country1,097 target enrollmentStarted: September 23, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
1,097
Locations
1
Primary Endpoint
Total triglycerides, mg/dL

Study Overview

Brief Summary

The goal of this clinical trial is to investigate the impact of nutritional interventions on glycemic and lipid profile factors among workers.

The main questions it aims to answer are:

Does nutritional interventions (include: nutritional education and Change in the Factory Restaurant's Menu improve glycemic and lipid profile factors among workers? Researchers will compare glycemic and lipid profile factors among workers before and after nutritional intervention .

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • be Arfa's company worker

Exclusion Criteria

  • individuals who were diagnosed with any type of cancer

Arms & Interventions

Arfa's company workers

Experimental

all interventions administer to this arm

Intervention: nutritional interventions include education and modifying company's restaurant menu (Behavioral)

Outcomes

Primary Outcomes

Total triglycerides, mg/dL

Time Frame: From enrollment to the end of intervention at 6 months

Total Cholesterol, mg/dL

Time Frame: From enrollment to the end of intervention at 6 months

Low-density lipoprotein, mg/dL

Time Frame: From enrollment to the end of intervention at 6 months

High-density lipoprotein, mg/dl

Time Frame: From enrollment to the end of intervention at 6 months

Fast blood sugar, mg/dL

Time Frame: From enrollment to the end of intervention at 6 months

serum glutamic oxaloacetic transaminase, IU/L

Time Frame: From enrollment to the end of intervention at 6 months

serum glutamic pyruvic transaminase, IU/L

Time Frame: From enrollment to the end of intervention at 6 months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Peyman Sarsangi
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Peyman Sarsangi

Mr. Peyman Sarasangi, [Principal Investigator]

Shahid Sadoughi University of Medical Sciences and Health Services

Study Sites (1)

Loading locations...

Similar Trials